Archive

Delve into the ongoing questions surrounding SA’s Cuba doctor programme and its importance in today’s healthcare landscape.

Explore the impact of scrapping medical tax credits on healthcare for nearly a million South Africans under the new NHI Act.

Learn how Bidvest’s partnership with Natco Pharma impacts Adcock Ingram and shareholder rights amid a new takeover bid.

Explore the impact of trade tariffs on the pharmaceutical industry with the new EU-US trade deal imposing up to 15% tariffs.

Learn about Cape Town’s innovative research in traumatic child brain injury and its potential global impact on treatment.

Learn how haemophilia gene therapy offers new hope for patients, thanks to breakthroughs led by South African researcher Johnny Mahlangu.

South Africa prepares for a revolutionary new TB vaccine aimed at preventing tuberculosis in adolescents and adults by 2028.

Understand the debate surrounding medical fraud in South Africa: Did the Section 59 inquiry focus too much on race?

An African form of type 1 diabetes challenges existing beliefs about the autoimmune response and its management.

A staggering exodus of medical professionals is crippling South Africa’s public health sector. Official figures reveal that nearly 6,000 doctors and nurses are resigning from state facilities every year. This devastating brain drain is placing the nation’s healthcare system under immense pressure. As a result, hospitals are critically understaffed and vulnerable communities are left without […]

Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.